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ABSTRACT
Objective: To describe the characteristics of pregnant
women with and without pregestational diabetes and to
estimate the prevalence of pregestational diabetes in
pregnant women recorded in a UK primary care
database.
Methods: The data source for this study is The Health
Improvement Network (THIN) primary care database.
Pregnant women with and without diabetes aged
16 years and over were identified using diagnostic
Read codes and prescriptions for antidiabetics from
medical records. Data were examined on: age, body
mass index (BMI), social deprivation, smoking,
ethnicity and glycaemic control. The prevalence of
pregestational diabetes was calculated by diabetes type
and calendar year between 1995 and 2012.
Results: Data from 400 434 pregnancies suggests that
women with pregestational diabetes were: older
(median 29, 32 vs 29 years for type 1, type 2 and
without diabetes, respectively), had higher BMI
(median 25.0, 30.4 vs 23.9 k/m2 for type 1, type 2 and
without diabetes, respectively) and were registered with
a general practice for longer than pregnant women
without diabetes. The prevalence of type 1 diabetes in
pregnancy increased from 1.56 to 4.09 per 1000
pregnancies between 1995 and 2015. For type 2
diabetes the increase was from 2.34 to 5.09 per 1000
pregnancies between 1995 and 2008 followed by a
more rapid increase to 10.62 per 1000 pregnancies by
2012.
Conclusions: Pregnant women with pregestational
diabetes were older, had higher BMI and were
registered for longer than women without diabetes.
The prevalence of type 1 and type 2 diabetes increased
in pregnancy. The prevalence of type 2 diabetes rose
more rapidly with a marked increase after 2008.
INTRODUCTION
Diabetes mellitus is a chronic metabolic
disease caused by a decrease in the produc-
tion of insulin or sensitivity to insulin. Type 1
diabetes is caused by the destruction of
insulin producing cells in the pancreas and
is most commonly diagnosed in childhood.
Type 2 diabetes is caused by cells insensitivity
to insulin and insufﬁcient production of
insulin. Type 2 diabetes is more common
among adults, although it is becoming
increasingly prevalent in adolescents.1
Pregestational diabetes is one of the com-
monest chronic conditions affecting preg-
nancy; in the UK 1 in every 250 pregnancies
is complicated by pregestational diabetes.2
And the prevalence is increasing, in the UK
the prevalence of pregestational diabetes
increased from 3.1 to 4.7 per 1000 births
between 1996–1998 and 2002–2004.3
Diabetes in pregnancy is associated with
increased risk of pregnancy complications
and adverse birth outcomes. Pregnancies
affected by pregestational diabetes are at an
increased risk of spontaneous abortion, cae-
sarean section, congenital anomalies and
perinatal mortality.3–7
The current literature on the prevalence
of diabetes in pregnancy is based on regional
or national samples selected from hospitals,
maternity units or small community-based
samples.3 8 9 We used data from UK primary
care records dating back to the 1990s.
The aims of this study were to examine
characteristics of pregnant women with and
Strengths and limitations of this study
▪ This study is one of the most comprehensive
studies of the prevalence of pregestational dia-
betes in pregnancy, based on electronic health
records in the UK.
▪ The data source for this study was a large
primary care database that is representative of
the UK population with over 3 million active
patients.
▪ The study only captures individuals who have
been diagnosed with diabetes in primary care as
the primary reason for data collection is patient
care and management not research.
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without pregestational diabetes, and to investigate the
time trend in the prevalence of pregestational diabetes
in pregnancy using data from a large primary care
database.
METHODS
Data source
For this study we used The Health improvement
Network (THIN) primary care database, which contains
longitudinal anonymised electronic primary care
records from 587 general practices, covering approxi-
mately 6% of the UK population.10 The database con-
tains information on: diagnoses, symptoms,
prescriptions, referrals, laboratory tests, basic demo-
graphics and social deprivation (recorded by Townsend
score). Diagnoses and symptoms are recorded during
consultations by practice staff using Read codes, a hier-
archical coding system used in UK primary care.11
In the UK 98% of the population is registered with a
general practitioner (GP) (family physician)12 and this
is reﬂected by THIN being broadly representative of the
UK population in terms of patient demographics,
chronic disease prevalence and death rates.13 Practices
in the THIN primary care database are located in all
nations of the UK, with a slight over-representation of
the South of England.13
Study population
We identiﬁed pregnant women aged 16 years and over,
who were registered with a general practice in THIN
and delivered a baby between 1 January 1995 and 31
December 2012. Two data quality measures developed
for use within THIN were applied to the data. These
data quality measures were; acceptable computer usage
(ACU) date and acceptable mortality rate (AMR)
date.14 15 ACU date is deﬁned as the practice recording
on average at least two drug prescriptions and two
medical records per patient per year, indicating the
practice is using their computing system fully for data
recording. AMR date is when the practice has compar-
able mortality rates to the rest of the UK, in accordance
with practice size and demography. Pregnancies were
only included after the later of the practice speciﬁc ACU
and AMR date. Using data after these dates improves the
quality.
Pregnant women with pregestational diabetes were
identiﬁed through diagnoses and prescriptions in their
electronic health records. Women who only had one
diagnostic code for diabetes or, prescription records
alone without a diabetic-speciﬁc diagnostic code were
excluded from the study as we were not certain of their
diabetic status. Women with a ﬁrst record of diabetes
dated after the start of pregnancy were also excluded so
that we could be certain we were studying diabetes types
1 and 2, and not gestational diabetes.
We generated an algorithm for classifying diabetes
type using different combinations of four variables.
The algorithm was discussed in a panel including clini-
cians. The four variables are: (1) whether a woman had
a type-speciﬁc diagnostic code; (2) the prescription
records; (3) age at ﬁrst record of diabetes and (4)
whether the woman was diagnosed with diabetes prior
to entering the practice. The type-speciﬁc diagnostic
Read code was given the most weight in the type classiﬁ-
cation algorithm; if a woman had a non-conﬂicting type-
speciﬁc Read code then they were initially classiﬁed as
having that type of diabetes. Prescriptions were then
looked at and if a woman had received long-term oral
antidiabetics prescriptions with or without insulin, any
oral antidiabetics without insulin, or no prescriptions
they were classiﬁed as having type 2 diabetes. Lastly, for
women who had conﬂicting or no type-speciﬁc diagnos-
tic Read codes we considered prescriptions along with
age at diagnosis and whether the women were diagnosed
prior to registration. In general if a woman had prescrip-
tions for insulin with or without short-term oral antidia-
betics, was <35 years old at diagnosis or ≥35 years and
diagnosed after registering with a practice they were clas-
siﬁed as having type 1 diabetes, and type 2 diabetes
otherwise.
After applying the classiﬁcation algorithm, if there
were women still unclassiﬁed then a manual review of
their entire medical records was undertaken.
Maternal characteristics
We compared pregnant women with and without dia-
betes in terms of: age; body mass index (BMI) prior to
pregnancy; smoking (coded as never, former or
current); Townsend score (coded as 1 least deprived to
5 most deprived); ethnicity (coded as white, black,
Asian, mixed or other); blood pressure; and glycated
haemoglobin (HbA1c) levels prior to pregnancy. We also
created a binary variable indicating whether a women
was overweight or not; women were classiﬁed as being
overweight if their BMI measured ≥25 kg/m2. All
characteristics, apart from maternal age, ethnicity and
Townsend score, were captured during the 12 months
prior to pregnancy. The record nearest to the start of
each pregnancy was taken. Any record of ethnicity prior
to pregnancy was selected and the Townsend score for
deprivation quintile nearest to the index pregnancy was
taken. Maternal age was deﬁned as age at the start of
pregnancy.
Townsend score,16 is a composite index score of owner
occupation, car ownership, overcrowding and unemploy-
ment based on a patient’s postcode and information
from the 2001 census data linked to each patients’
postcode.
Statistical methods
Characteristics of pregnant women with and without dia-
betes were compared using median and the IQR for
continuous variables or number and per cent for cat-
egorical variables calculated for by diabetes type and
women without diabetes separately. We randomly
2 Coton SJ, et al. BMJ Open 2016;6:e009494. doi:10.1136/bmjopen-2015-009494
Open Access
selected a single pregnancy per women for these
calculations.
We calculated the prevalence of pregestational dia-
betes by calendar year of delivery and diabetes type for
the years 1995–2012 inclusive. For women with multiple
eligible pregnancies recorded all pregnancies were
included in the prevalence calculations.
All analyses were performed using Stata V.13
(StataCorp, College Station, Texas, USA).
RESULTS
We identiﬁed 503 952 pregnancies in THIN between 1
January 1995 and 31 December 2012. We removed 95 578
pregnancies as they occurred prior to the practice-speciﬁc
AMR and ACU date and 1747 pregnancies as they
occurred before the mother was 16 years of age. A further
6193 pregnancies were removed because we could not
conﬁrm the diabetic status of the mother before the preg-
nancy began. The ﬁnal cohort consistent of 400 434 preg-
nancies to 301 794 women recorded in THIN (ﬁgure 1).
The majority of women had a single pregnancy (55%) and
only 2% of women had four or more pregnancies.
Pregestational diabetes affected 1% of pregnancies
from the total cohort: 0.3% (1303/400 434) with type 1
diabetes and 0.5% (2074/400 434) with type 2 diabetes.
For women with more than one pregnancy, a single
pregnancy was randomly selected for comparison
between women with and without diabetes.
Pregestational diabetes affected 0.85% of this partial
cohort: 0.3% (999/301 794) with type 1 diabetes and
0.5% (1572/301 794) with type 2 diabetes (table 1).
Pregnant women with pregestational diabetes were:
older, had higher BMI, were more likely to be over-
weight, were less likely to smoke and were registered
with a general practice for longer prior to pregnancy
when compared with pregnant women without diabetes.
The median age was 29, 32 and 29 years for pregnant
women with type 1 diabetes, type 2 diabetes and without
diabetes, respectively. The median BMI was 25.0, 30.4
and 23.9 kg/m2 for pregnant women with type 1 dia-
betes, type 2 diabetes and without diabetes, respectively.
Seventy per cent of pregnant women with type 2 dia-
betes were overweight compared with 52% of pregnant
women with type 1 diabetes and 32% of pregnant
women without diabetes. The median length of registra-
tion prior to pregnancy was 3 years for pregnant women
with type 1 and type 2 diabetes and 2 years for pregnant
women without diabetes (table 1).
Pregnant women with type 1 diabetes had higher blood
glucose concentrations when compared with pregnant
women with type 2 diabetes. Median HbA1c concentra-
tions prior to pregnancy were 62.8 mmol/mol (7.9%) for
women with type 1 diabetes compared with 53.0 mmol/
mol (7.0%) for women with type 2 diabetes (table 1).
Pregnant women with type 1 diabetes were also more
likely to have blood glucose control tested prior to preg-
nancy when compared with pregnant women with type 2
diabetes; 56% vs 31% for HbA1c, 18% vs 24% for random
plasma glucose and 4% vs 7% for fasting plasma glucose.
Pregnant women with type 2 diabetes were more likely
to be non-smokers or ex-smokers, and were more socially
deprived than pregnant women with type 1 diabetes
(table 1). Forty-six per cent of pregnant women with
type 2 diabetes were non-smokers, and 33% were
ex-smokers at the start of their pregnancy compared
with 43% and 31% of pregnant women with type 1 dia-
betes. Eighteen per cent of pregnant women with type 2
diabetes were in the most socially deprived Townsend
quintile compared with 14% of pregnant women with
type 1 diabetes (table 1). Diastolic and systolic blood
pressure and ethnicity were similar across the three
groups, although approximately half of the women did
not have their ethnicity recorded.
The prevalence of pregestational type 1 diabetes and
type 2 diabetes in pregnancy increased over the study
Figure 1 Flow diagram of study
cohort development.
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period (ﬁgure 2). The prevalence of type 1 diabetes in
pregnancy increased from 1.56 to 4.09 per 1000 pregnan-
cies between 1995 and 2012, a 162% increase over
17 years. The prevalence of type 2 diabetes in pregnancy
increased from 2.34 to 5.09 per 1000 pregnancies
between 1995 and 2008. After 2008 the prevalence of
type 2 diabetes in pregnancy increased more rapidly
from 6.74 to 10.62 per 1000 pregnancies between 2009
and 2012 (ﬁgure 2). Over the study period, the preva-
lence of type 2 diabetes in pregnancy increased by 354%.
DISCUSSION
Summary of main findings
Women with pregestational diabetes were: older, had
higher BMI, were more likely to be overweight, and were
registered with a general practice longer prior to preg-
nancy when compared with pregnant women without
pregestational diabetes. The prevalence of type 1 and
type 2 diabetes in pregnancy increased between 1995
and 2012 with a sharper rise in type 2 diabetes, in par-
ticular in the last 5 years of the study period.
Table 1 Comparison of characteristics of women with and without pregestational diabetes mellitus
Type 1 diabetes mellitus
N=999
Type 2 diabetes mellitus
N=1572
No diabetes mellitus
N=299 223
N Median (IQR) N Median (IQR) N Median (IQR) p Value
Maternal age (years)* 999 29.0 (25.0, 33.0) 1572 32.0 (28.0, 35.0) 299 223 29.0 (25.0, 33.0) >0.001
BMI (kg/m2)† 875 25.0 (22.7, 28.5) 1342 30.4 (25.5, 35.6) 196 368 23.9 (21.4, 27.6) >0.001
Diastolic blood pressure
(mm Hg)†
874 74.0 (69.0, 80.0) 1256 78.0 (70.0, 83.0) 194 217 71.0 (67.0, 80.0) >0.001
Systolic blood pressure
(mm Hg)†
876 119.0 (110.0, 128.0) 1256 120.0 (110.0, 130.0) 194 528 117.0 (110.0, 124.0) >0.001
HbA1c†
Percentage 557 7.9 (7.0, 9.3) 485 7.0 (6.0, 8.4) 18 5.4 (5.2, 7.1) >0.001
mmol/moL 557 62.8 (53.0, 78.1) 485 53.0 (42.0, 68.3) 18 35.0 (33.0, 54.1)
Random plasma glucose
(mmol/L)†
179 8.2 (6.0, 11.3) 376 5.7 (4.7, 8.3) 17 779 4.7 (4.3, 5.1) >0.001
Fasting plasma
glucose (mmol/L)†
37 6.7 (5.2, 9.9) 108 6.3 (4.9, 8.1) 3210 4.7 (4.3, 5.0) >0.001
Length of prior records
(years)
999 3.0 (1.0, 6.0) 1572 3.0 (1.0, 7.0) 299 223 2.0 (1.0, 5.0) >0.001
N Per cent (95% CI) N Per cent (95% CI) N Per cent (95% CI)
Overweight†
No 354 35.4 (32.5 to 38.5) 243 15.5 (13.8 to 17.3) 100 340 33.5 (33.4 to 33.7) >0.001
Yes 521 52.2 (49.0 to 55.2) 1099 69.9 (67.6 to 72.1) 96 028 32.1 (31.9 to 32.3)
Missing 124 12.4 (10.5 to 14.6) 230 14.6 (13.0 to 16.5) 102 855 34.4 (34.2 to 34.5)
Smoking status†
Never 428 42.8 (39.8 to 45.9) 719 45.7 (43.3 to 48.2) 127 379 42.6 (42.4 to 42.8) >0.001
Former 305 30.5 (27.8 to 33.5) 513 32.6 (30.4 to 35.0) 88 820 29.7 (29.5 to 29.9)
Current 260 26.0 (23.4 to 28.8) 339 21.6 (19.6 to 23.7) 80 186 26.8 (26.6 to 27.0)
Missing 6 0.6 (0.3 to 1.3) 1 0.1 (0.01 to 0.5) 2838 0.9 (0.9 to 1.0)
Ethnic group‡
White 421 42.1 (39.1 to 45.2) 587 37.3 (35.0 to 39.8) 106 507 35.6 (35.4 to 35.8) >0.001
Mixed 5 0.5 (0.2 to 1.2) 12 0.8 (0.4 to 1.3) 1234 0.4 (0.4 to 0.4)
Black 7 0.7 (0.3 to 1.5) 56 3.6 (2.8 to 4.6) 4725 1.6 (1.5 to 1.6)
Asian 17 1.7 (1.1 to 2.7) 138 8.8 (7.5 to 10.3) 9248 3.1 (3.0 to 3.2)
Other 9 0.9 (0.5 to 1.7) 26 1.7 (1.1 to 2.4) 3369 1.1 (1.1 to 1.2)
Missing 540 54.1 (51.0 to 57.1) 753 47.9 (45.4 to 50.4) 174 140 58.2 (58.0 to 58.4)
Townsend quintile§
1 223 22.3 (19.8 to 25.0) 251 16.0 (14.2 to 17.9) 65 220 21.6 (21.6 to 21.9) >0.001
2 195 19.1 (17.2 to 22.1) 263 16.7 (15.0 to 18.7) 55 909 18.6 (18.5 to 18.8)
3 200 20.0 (17.6 to 22.6) 341 21.7 (19.7 to 23.8) 607 815 20.3 (20.2 to 20.5)
4 195 19.5 (17.2 to 22.1) 344 21.9 (19.9 to 24.0) 58 600 19.6 (19.4 to 19.7)
5 143 14.3 (12.3 to 16.6) 280 17.8 (16.0 to 19.8) 44 303 14.8 (14.7 to 14.9)
Missing 43 4.3 (3.2 to 5.6) 93 5.9 (4.9 to 7.2) 14 376 4.8 (4.7 to 4.9)
*Age at start of pregnancy.
†Recorded in the 12 months prior to pregnancy.
‡Recorded at any time prior to pregnancy.
§Record nearest to the start of the pregnancy was taken.
BMI, body mass index; HbA1c, glycated haemoglobin.
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Comparison with existing literature
There are few studies with the primary objective to inves-
tigate the prevalence of pregestational diabetes in preg-
nancy3 9 17–23 of these studies only one is based in the
UK.3 Bell et al,3 studied the trends in prevalence of preg-
estational diabetes in pregnancy in maternity units in
the North of England between 1996 and 2004, and
found comparable prevalence of type 1 diabetes but
much lower prevalence of type 2 diabetes than our
study. In 2002–2004 they found a prevalence of 3.5 per
1000 births of type 1 and 1.2 per 1000 birth of type 2
diabetes. Of the non-UK-based studies de Andrés et al21
found in Spain that the prevalence of pregestational dia-
betes increased from 0.2% in 2001 to 0.27% in 2008.
Lawrence et al,9 in the USA also found that the preva-
lence of pregestational diabetes more than doubled
between 1999 and 2005 from 0.11% to 0.55% equivalent
to our ﬁndings. Bardenheier et al19 used state inpatient
databases for 19 US states and found pregestational dia-
betes increased from 0.65 per 100 deliveries to 0.89 per
100 deliveries between 2000 and 2010. The prevalence is
comparable to our study in 2000 but the prevalence in
the US did not increase as rapidly. Feig et al’s23 recent
study using administrative health claims data for
Ontario, Canada found that the prevalence of pregesta-
tional diabetes increased from 0.7% in 1996 to 1.5% in
2010, which are comparable to our ﬁndings for the
same years: 0.3% in 1996 to 1.2% in 2010.
The Conﬁdential Enquiry into Maternal and Child
Health (CEMACH) in England, Wales and Northern
Ireland reported prevalence of pregestational diabetes
between 1 March 2002 and 28 February 2003 as part of a
series of ﬁndings.8 They found a prevalence of type 1 and
type 2 diabetes of 2.7 and 1.0 per 1000 births, respectively.
Our ﬁndings are comparable to CEMACH for the preva-
lence of type 1 diabetes in pregnancy in 2002 but higher
for type 2 diabetes in pregnancy in 2002. The CEMACH
enquiry8 found pregnant women with type 1 diabetes are
different to pregnant women with type 2 diabetes in
terms of age, ethnicity and parity. They found pregnant
women with type 2 diabetes were older than women with
type 1 diabetes; median age 33.5 years compared with
30.0 years, respectively. These results compare favourably
to the ﬁndings presented in this paper.
Globally there has been an increase in the prevalence
of type 2 diabetes among women of child-bearing age.
There have been a number of reviews on the prevalence
of type 2 diabetes in pregnancy.24–26 Lapolla et al,25
reported type 2 diabetes affecting between 3.2% and
70% of pregnancies globally compared with our ﬁnding
of 52% across the study period.
Strengths and limitations
THIN is a large primary care database capturing real-life
data from primary care and this was a signiﬁcant strength
of this study. However, THIN was not created for research
purposes rather, it is clinical data entry system.
First, there is a large amount of missing data particu-
larly for overweight and ethnicity variables. For pregnant
women with type 1 and type 2 diabetes 13% and 16%
had missing BMI data compared to 34% missing for
pregnant women without diabetes. Whereas for ethnicity
approximately half of pregnant women have missing
data across the three categories; 54%, 47% and 58% for
women with type 1 diabetes, type 2 diabetes and without
diabetes, respectively.
A potential limitation of this study is underestimation
of diabetes. First, we used diagnostic Read codes, pre-
scriptions and free text entered by GPs to conﬁrm dia-
betes and we excluded those with only one recording of
diabetes and those receiving prescriptions for antidia-
betics without a diagnostic code. Second, as many of
Figure 2 Prevalence of
pregestational diabetes mellitus in
pregnancy by year and diabetes
type.
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half those with type 2 diabetes are undiagnosed as symp-
toms of hyperglycaemia go undetected.27 Third, the
algorithm used to identify and classify women with type
1 or type 2 diabetes was speciﬁc, limiting any false-
positive cases of diabetes. Finally, our data is restricted to
general practice attenders and women with diabetes
who receive their care privately or in specialist clinics
would have been missed, contributing to under-
reporting of prevalence. Despite these considerations,
the study reported higher than expected levels of dia-
betes then has previously been reported.
Clinical implications
The increase in both type 1 diabetes and especially type 2
diabetes with a sharp rise in past few years is of special
concern to primary care doctors who have to be prepared
to work more closely with secondary care on timely man-
agement of this problem. There is an established link
between diabetes in pregnancy and adverse pregnancy
outcomes, including congenital anomalies, perinatal
mortality, spontaneous abortion, and delivery by caesar-
ean section.3 5 The poorer glycaemic control of women
with type 1 diabetes compared with women with type 2
diabetes prior to pregnancy needs particular attention in
terms of its risk to the pregnancy and the baby.
It is known that two-thirds of women with pregesta-
tional diabetes receive suboptimal preconception care.8
In this study we found that half of women with type 1 dia-
betes and two-thirds of women with type 2 diabetes did
not have a HbA1c recorded in general practice in the
12 months prior to pregnancy. With the high levels of
problems in primary care, GPs can play a pivotal role in
delivering preconception care to reduce the risk of
adverse outcomes.28–30 This can include both preventive
management of all women with diabetes of child-bearing
age and more speciﬁc management of diabetes during
pregnancy. There is a growing need for the development
and evaluation of such interventions in primary care.
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